The Impact of KRAS Status on the Required Surgical Margin Width for Colorectal Liver Metastasis Resection

Local recurrence after colorectal liver metastasis (CRLM) resection severely affects survival; however, the required surgical margin width remains controversial. This study investigated the impact of KRAS status on surgical margin width and local recurrence rate (LRR) post-CRLM resection. Overall, 146 resected CRLMs with KRAS status (wild-type KRAS (wtKRAS): 98, KRAS mutant (mKRAS): 48) were included. The LRR for each group, R1 (margin positive) and R0 (margin negative), was analyzed by KRAS status. R0 was further stratified into Ra (margin ≥ 5 mm) and Rb (margin < 5 mm). Patients with local recurrence had significantly worse 5-year overall survival than those without local recurrence (p = 0.0036). The mKRAS LRR was significantly higher than wtKRAS LRR (p = 0.0145). R1 resection resulted in significantly higher LRRs than R0 resection for both wtKRAS and mKRAS (p = 0.0068 and p = 0.0204, respectively), and while no significant difference was observed in the Ra and Rb LRR with wtKRAS, the Rb LRR with mKRAS (33.3%) was significantly higher than Ra LRR (5.9%) (p = 0.0289). Thus, R0 resection is sufficient for CRLM with wtKRAS; however, CRLM with mKRAS requires resection with a margin of at least 5 mm to prevent local recurrence.

[1]  D. Zacharoulis,et al.  Colorectal Cancer Liver Metastases: Is an R1 Hepatic Resection Accepted? , 2022, Clinics and practice.

[2]  A. Benson,et al.  Treatment of Metastatic Colorectal Cancer: ASCO Guideline , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Ryosuke Kita,et al.  Indocyanine green plasma clearance rate and 99mTc-galactosyl human serum albumin single-photon emission computed tomography evaluated preoperative remnant liver , 2022, World journal of clinical cases.

[4]  S. Faraj,et al.  Histopathological factors versus margin size in single colorectal liver metastases: Does a 1-cm margin size matter? , 2022, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[5]  J. Fuster,et al.  Impact of microscopic incomplete resection for colorectal liver metastases on surgical margin recurrence: R1‐Contact vs R1 < 1 mm margin width , 2022, Journal of hepato-biliary-pancreatic sciences.

[6]  K. Uryuhara,et al.  Resection strategy for colorectal liver metastasis focusing on intrahepatic vessels and resection margins , 2021, Surgery Today.

[7]  C. Stafford,et al.  Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma , 2020, Annals of Surgical Oncology.

[8]  I. Zlobec,et al.  Tumour budding and its clinical implications in gastrointestinal cancers , 2020, British Journal of Cancer.

[9]  J. Hodson,et al.  The effects of resection margin and KRAS status on outcomes after resection of colorectal liver metastases. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[10]  J. García-Foncillas,et al.  KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study , 2020, Cells.

[11]  G. Torzilli,et al.  Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.

[13]  F. Giuliante,et al.  The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas , 2019, Surgery.

[14]  Prashanth Rawla,et al.  Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors , 2019, Przeglad gastroenterologiczny.

[15]  T. Yamanaka,et al.  Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study1 , 2018, Neoplasia.

[16]  J. Vauthey,et al.  RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases , 2018, Annals of Surgical Oncology.

[17]  T. Pawlik,et al.  Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis , 2017, Annals of surgery.

[18]  E. Ziv,et al.  Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases , 2017, Oncotarget.

[19]  Y. Kamatani,et al.  Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project , 2017, Journal of epidemiology.

[20]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  N. Hamdy,et al.  Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study , 2016, Hematology.

[22]  Hanan H. Rizk,et al.  Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4 , 2016, PloS one.

[23]  N. Hamdy,et al.  Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C , 2016, BMC Gastroenterology.

[24]  K. Muro,et al.  Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study , 2015, EBioMedicine.

[25]  S. Truant,et al.  Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[26]  N. Gusani,et al.  Overall survival by pattern of recurrence following curative intent surgery for colorectal liver metastasis , 2014, Journal of surgical oncology.

[27]  C. Hsieh,et al.  Hepatic hemodynamic changes during liver transplantation: a review. , 2014, World journal of gastroenterology.

[28]  M. Tez,et al.  Role of surgery in colorectal cancer liver metastases. , 2014, World journal of gastroenterology.

[29]  Viktor H. Koelzer,et al.  The Tumor Border Configuration of Colorectal Cancer as a Histomorphological Prognostic Indicator , 2014, Front. Oncol..

[30]  Steven A. Curley,et al.  RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases , 2013, Annals of surgery.

[31]  R. Parks,et al.  Surgery for Colorectal Liver Metastases , 2013, Digestive Surgery.

[32]  Sabine Tejpar,et al.  Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. , 2010, The Lancet. Oncology.

[33]  M. Jacob,et al.  A Rational Approach to Perioperative Fluid Management , 2008, Anesthesiology.

[34]  Z. Hamady,et al.  Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  Evelyne M. Loyer,et al.  Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases , 2005, Annals of surgery.

[36]  Yoshihiro Sakamoto,et al.  Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. , 2002, Archives of surgery.

[37]  J. Cuzick,et al.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases , 1986, Histopathology.